| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
105,839 |
86,074 |
$8.56M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
104,313 |
84,497 |
$6.83M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
9,505 |
8,092 |
$976K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
5,708 |
4,990 |
$436K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
10,415 |
8,383 |
$420K |
| 99254 |
|
1,482 |
1,344 |
$234K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
4,127 |
3,386 |
$204K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
2,495 |
2,150 |
$204K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
8,384 |
2,473 |
$191K |
| 93000 |
|
7,145 |
6,156 |
$135K |
| 99051 |
|
10,278 |
8,098 |
$123K |
| 99222 |
Initial hospital care, per day, moderate complexity |
3,532 |
2,627 |
$122K |
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
502 |
398 |
$120K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
3,864 |
3,430 |
$112K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
18,070 |
13,440 |
$102K |
| L4361 |
Walking boot, pneumatic and/or vacuum, with or without joints, with or without interface material, prefabricated, off-the-shelf |
461 |
374 |
$94K |
| 99215 |
Prolong outpt/office vis |
2,142 |
1,829 |
$84K |
| 73630 |
|
2,550 |
1,929 |
$58K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
726 |
602 |
$57K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
1,821 |
1,569 |
$56K |
| 3044F |
|
3,965 |
3,375 |
$56K |
| 95117 |
|
5,306 |
2,171 |
$55K |
| L3000 |
Foot, insert, removable, molded to patient model, 'ucb' type, berkeley shell, each |
166 |
109 |
$54K |
| 0002A |
|
2,786 |
1,447 |
$52K |
| 0001A |
|
3,033 |
1,548 |
$50K |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
292 |
280 |
$49K |
| 20611 |
|
1,357 |
1,117 |
$46K |
| 87428 |
|
1,711 |
1,469 |
$45K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
417 |
357 |
$44K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
1,763 |
1,113 |
$42K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
616 |
397 |
$41K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
377 |
347 |
$41K |
| 90686 |
|
2,390 |
1,983 |
$38K |
| 88342 |
|
1,095 |
907 |
$35K |
| 88307 |
|
518 |
445 |
$34K |
| 93015 |
|
426 |
376 |
$33K |
| 99221 |
|
449 |
375 |
$32K |
| 94727 |
|
1,459 |
1,297 |
$30K |
| 99223 |
Prolong inpt eval add15 m |
661 |
555 |
$29K |
| 94729 |
|
1,566 |
1,390 |
$29K |
| 80305 |
|
1,628 |
1,502 |
$29K |
| 94060 |
|
1,567 |
1,392 |
$27K |
| 76820 |
|
629 |
408 |
$26K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
1,209 |
498 |
$23K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,258 |
1,898 |
$22K |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
705 |
536 |
$22K |
| 99205 |
Prolong outpt/office vis |
311 |
282 |
$21K |
| 0003A |
|
1,193 |
543 |
$20K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,633 |
1,331 |
$20K |
| 95251 |
|
713 |
629 |
$20K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
175 |
155 |
$17K |
| G0008 |
Administration of influenza virus vaccine |
1,571 |
1,287 |
$16K |
| 90682 |
|
704 |
610 |
$16K |
| 0012A |
|
910 |
459 |
$15K |
| 0064A |
|
829 |
427 |
$15K |
| 73564 |
|
678 |
458 |
$15K |
| 99442 |
|
608 |
566 |
$14K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
147 |
147 |
$14K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
151 |
137 |
$14K |
| 0011A |
|
1,033 |
465 |
$14K |
| H1003 |
Prenatal care, at-risk enhanced service; education |
1,208 |
1,055 |
$12K |
| 1125F |
|
730 |
678 |
$11K |
| 99406 |
|
1,327 |
1,086 |
$11K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
73 |
71 |
$11K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,274 |
1,116 |
$10K |
| 0072A |
|
540 |
270 |
$10K |
| 3051F |
|
352 |
282 |
$10K |
| 99443 |
|
293 |
275 |
$9K |
| 99233 |
Prolong inpt eval add15 m |
526 |
246 |
$9K |
| 0071A |
|
541 |
271 |
$9K |
| 73130 |
|
295 |
240 |
$7K |
| 81003 |
|
530 |
493 |
$7K |
| 1126F |
|
442 |
417 |
$6K |
| 0031A |
|
316 |
168 |
$6K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
81 |
63 |
$5K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
263 |
230 |
$5K |
| 73610 |
|
173 |
146 |
$4K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
53 |
51 |
$4K |
| 91320 |
|
83 |
75 |
$4K |
| 90656 |
|
233 |
214 |
$4K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
179 |
145 |
$4K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
30 |
27 |
$4K |
| 3052F |
|
130 |
107 |
$3K |
| 99441 |
|
224 |
210 |
$3K |
| 11721 |
|
86 |
86 |
$3K |
| 73030 |
|
77 |
68 |
$3K |
| 76801 |
|
26 |
25 |
$3K |
| 0004A |
|
145 |
77 |
$3K |
| 81025 |
|
433 |
356 |
$3K |
| 95024 |
|
16 |
15 |
$2K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
67 |
61 |
$2K |
| 0124A |
|
115 |
66 |
$2K |
| 0054A |
|
103 |
49 |
$2K |
| 94010 |
|
74 |
66 |
$2K |
| 90662 |
|
342 |
265 |
$2K |
| 93356 |
|
67 |
62 |
$2K |
| 88304 |
|
165 |
144 |
$2K |
| 3046F |
|
73 |
58 |
$2K |
| 94618 |
|
65 |
56 |
$2K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
13 |
13 |
$2K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
46 |
44 |
$2K |
| 99385 |
|
12 |
12 |
$2K |
| 0134A |
|
64 |
34 |
$2K |
| 90480 |
|
83 |
76 |
$1K |
| 72100 |
|
56 |
49 |
$1K |
| 0052A |
|
74 |
33 |
$1K |
| 20610 |
|
103 |
89 |
$1K |
| 99417 |
Prolong home eval add 15m |
60 |
30 |
$1K |
| 99459 |
|
58 |
56 |
$1K |
| J2785 |
Injection, regadenoson, 0.1 mg |
255 |
225 |
$1K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
12 |
12 |
$1K |
| 96160 |
|
461 |
286 |
$1K |
| 88141 |
|
47 |
37 |
$988.86 |
| 0051A |
|
57 |
21 |
$974.00 |
| 82803 |
|
26 |
25 |
$969.15 |
| 90648 |
|
87 |
50 |
$884.64 |
| G0009 |
Administration of pneumococcal vaccine |
85 |
82 |
$881.85 |
| 99495 |
|
27 |
27 |
$877.44 |
| 90715 |
|
26 |
24 |
$862.02 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
43 |
40 |
$819.80 |
| 87807 |
|
76 |
69 |
$785.20 |
| 73502 |
|
31 |
29 |
$764.92 |
| 93793 |
|
660 |
322 |
$618.35 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
293 |
246 |
$562.69 |
| 88112 |
|
16 |
15 |
$556.78 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
27 |
26 |
$554.88 |
| 99496 |
|
14 |
13 |
$497.63 |
| H1000 |
Prenatal care, at-risk assessment |
12 |
12 |
$480.00 |
| 0013A |
|
25 |
12 |
$480.00 |
| 94664 |
|
33 |
25 |
$460.60 |
| 82962 |
|
143 |
127 |
$370.62 |
| 81000 |
|
114 |
110 |
$365.76 |
| 99307 |
|
36 |
27 |
$292.41 |
| 90670 |
|
43 |
30 |
$232.80 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
17 |
14 |
$191.38 |
| 3008F |
|
23,505 |
21,070 |
$120.00 |
| 3074F |
|
13,102 |
11,899 |
$75.00 |
| 87081 |
|
13 |
13 |
$65.33 |
| 85610 |
|
23 |
12 |
$46.36 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
49 |
48 |
$30.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
22 |
13 |
$11.25 |
| 3075F |
|
676 |
629 |
$8.79 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
17 |
14 |
$2.04 |
| 91300 |
|
53 |
36 |
$0.04 |
| 0502F |
|
14,768 |
11,580 |
$0.00 |
| 1159F |
|
10,177 |
9,149 |
$0.00 |
| 3078F |
|
11,076 |
10,090 |
$0.00 |
| 1160F |
|
3,222 |
2,912 |
$0.00 |
| 3077F |
|
181 |
164 |
$0.00 |
| 3079F |
|
2,626 |
2,422 |
$0.00 |
| 3048F |
|
267 |
234 |
$0.00 |
| 4010F |
|
502 |
452 |
$0.00 |
| 3049F |
|
73 |
66 |
$0.00 |
| 90677 |
|
30 |
13 |
$0.00 |
| 3080F |
|
26 |
24 |
$0.00 |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
50 |
49 |
$0.00 |
| 91301 |
|
15 |
12 |
$0.00 |
| 90732 |
|
15 |
14 |
$0.00 |
| 36600 |
|
27 |
25 |
$-5.32 |